Clinical trial

Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee

NCT00450112 · Seikagaku Corporation, Industry · Completed

Key facts

NCT number NCT00450112
Title Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee
Official title A Multi-Center Extension and Open-Label Study of a Single or Repeat Intra-Articular Injection of Gel-200 in Osteoarthritis of the Knee.
Lead sponsor Seikagaku Corporation, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Osteoarthritis of the Knee
Intervention type Device
Interventions Gel-200
Enrollment 202
Start date Mar 1, 2007
Primary completion Jun 1, 2009
Completion Jun 1, 2009
First posted Mar 21, 2007
Last update posted Aug 22, 2011
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies